Company: LGN
Filing Date: 2025-08-25
Form Type: S-1/A
Source: 0001193125-25-186788
Chunk: 141

Company: Legence Corp.
Filing Date: 2025-08-25
Form: S-1/A
Chunk 141
---
 |     12.1 | %  |

| (1) | Represents costs incurred in connection with our debt refinancings in each of the periods presented. |

| (2) | Refer to “Note 5—Goodwill and Intangible Assets” in the Notes to Consolidated Financial 
 Statements, for details on the nature of the impairment.                                |

| (3) | For the three months ended June 30, 2025, March 31, 2025, December 31, 2024, September 30,                                                                                                                                          
 2024, June 30, 2024 and March 31, 2024, the figures include $0.0 million, $0.2 million, $0.0 million, $0.2 million, $1.4 million and $4.1 million, respectively, of acquisition costs recorded in acquisition-related               
 costs and $0.3 million, $1.3 million, $2.1 million, $0.7 million, $0.7 million and $0.0 million, respectively, of acquisition integration costs recorded in selling, general and administrative costs in the Consolidated Condensed 
 Statement of Operations.                                                                                                                                                                                                            |

| (4) | Represents consulting and initial upfront costs associated with implementing and optimizing certain enterprise 
 resource planning systems, including IFS, Onestream and Ceridian Dayforce.                                     |

| (5) | Represents (i) consulting costs associated with rebranding efforts in connection with our name change to                                                                                                                                           
 Legence that we do not expect to recur in the future, (ii) upfront consulting and out-of-pocket costs related to developing and launching the cross-selling framework amongst our brands, many of which were more recently acquired and integrated 
 into the Legence brand, (iii) consulting and legal fees associated with education and marketing efforts for our clients with respect to utilizing certain government incentive                                                                     |

102

| programs and (iv) consulting, legal, accounting, and other expenses in connection with non-recurring extraordinary company transactions, including fees related to our IPO that did not meet 
 the requirements to be deferred issuance costs.                                                                                                                                              |

Backlog and Awarded Contracts and Book-to-BillRatio We track backlog and awarded contracts. We believe that these measures enable us to more effectively forecast our future results and working capital needs, as well as better identify future operating trends that may not otherwise be apparent. We believe this measure is also useful for investors in forecasting our future results and comparing us to our